HEALTHCARE INSTITUTE OF NEW JERSEY for HEALTHCARE INSTITUTE OF NEW JERSEY
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
promoting awareness and advocacy of the biopharmaceutical and medical technology industry in New Jersey Eshoo-Barton Pathways to Biosimilars Act HR 1548 Kennedy Pathways to Biosimilars Act Chronic disease prevention and treatment incentives in health care reform America's Affordable Health Choices Act HR.3200 America's Healthy Future Act HR 2502 Comparative Effectiveness Research Act of 2009
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DUTHIE | — |
| ROBERT D FRANKS | Member of Congress 1992-2000 |
| STEVE ISSENMAN | Congressional Page1987-1988 Intern 1990 |
| SARAH G KAN | Congressional Aid 1999-2002 |
Medicare/Medicaid MMM
Advocating on behalf of Medicare Part D open access and encouraging open market access to medications
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DUTHIE | — |
| ROBERT D FRANKS | Member of Congress 1992-2000 |
| SARAH G KAN | Congressional Aid 1999-2002 |
Affiliated organisations
| Organisation | Location |
|---|---|
| PARTNERSHIP TO FIGHT CHRONIC DISEASE/ | Washington, DC, US |
| PHRMA | Washington, DC, US |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.